Preliminary study of tumor heterogeneity in imaging predicts two year survival in pancreatic cancer patients

Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers in the United States with a five-year survival rate of 7.2% for all stages. Although surgical resection is the only curative treatment, currently we are unable to differentiate between resectable patients with occult metastati...

Descripción completa

Detalles Bibliográficos
Autores principales: Chakraborty, Jayasree, Langdon-Embry, Liana, Cunanan, Kristen M., Escalon, Joanna G., Allen, Peter J., Lowery, Maeve A., O’Reilly, Eileen M., Gönen, Mithat, Do, Richard G., Simpson, Amber L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5720792/
https://www.ncbi.nlm.nih.gov/pubmed/29216209
http://dx.doi.org/10.1371/journal.pone.0188022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5720792/
https://www.ncbi.nlm.nih.gov/pubmed/29216209
http://dx.doi.org/10.1371/journal.pone.0188022

Ejemplares similares